Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study
Open Access
- 17 February 2005
- Vol. 330 (7488) , 389
- https://doi.org/10.1136/bmj.330.7488.389
Abstract
Objective To compare the risk of non-fatal self harm and suicide in patients taking selective serotonin reuptake inhibitors (SSRIs) with that of patients taking tricyclic antidepressants, as well as between different SSRIs and different tricyclic antidepressants. Design Nested case-control study. Setting Primary care in the United Kingdom. Participants 146 095 individuals with a first prescription of an antidepressant for depression. Main outcome measures Suicide and non-fatal self harm. Results 1968 cases of non-fatal self harm and 69 suicides occurred. The overall adjusted odds ratio of non-fatal self harm was 0.99 (95% confidence interval 0.86 to 1.14) and that of suicide 0.57 (0.26 to 1.25) in people prescribed SSRIs compared with those prescribed tricyclic antidepressants. We found little evidence that associations differed over time since starting or stopping treatment. We found some evidence that risks of non-fatal self harm in people prescribed SSRIs compared with those prescribed tricyclic antidepressants differed by age group (interaction P = 0.02). The adjusted odds ratio of non-fatal self harm for people prescribed SSRIs compared with users of tricylic antidepressants for those aged 18 or younger was 1.59 (1.01 to 2.50), but no association was apparent in other age groups. No suicides occurred in those aged 18 or younger currently or recently prescribed tricyclic antidepressants or SSRIs. Conclusion We found no evidence that the risk of suicide or non-fatal self harm in adults prescribed SSRIs was greater than in those prescribed tricyclic antidepressants. We found some weak evidence of an increased risk of non-fatal self harm for current SSRI use among those aged 18 or younger. However, preferential prescribing of SSRIs to patients at higher risk of suicidal behaviour cannot be ruled out.Keywords
This publication has 14 references indexed in Scilit:
- Antidepressants and the Risk of Suicidal BehaviorsJAMA, 2004
- Repetition of deliberate self-harm and subsequent suicide risk: Long-term follow-up study of 11 583 patientsThe British Journal of Psychiatry, 2004
- Antidepressants and suicide: what is the balance of benefit and harmBMJ, 2004
- The General Practice Research DatabaseDrug Safety, 2004
- Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake InhibitorsPsychotherapy and Psychosomatics, 2003
- Deliberate self-harm in Oxford, 1990–2000: a time of change in patient characteristicsPsychological Medicine, 2003
- Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality dataBMJ, 2002
- Antidepressants and suicideBMJ, 1995
- Prevention of suicide: aspirations and evidenceBMJ, 1994
- Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.1987